W Frederick Driscoll

Affiliations

  • Director at Cellectar Biosciences Inc. (CLRB), 2025-02-18
  • at Cue Biopharma Inc. (CUE), 2025-01-03
  • at Mei Pharma Inc. (MEIP), 2023-10-12
  • Interim Cfo at Invivyd Inc. (IVVD), 2022-10-13
  • Chief Financial Officer at Renovacor Inc. (RCOR), 2022-03-28
  • Chief Financial Officer at Flexion Therapeutics Inc (FLXN), 2021-11-19
  • Director at Nantkwest Inc. (NK), 2020-08-13
  • Interim Cfo & Interim Treas at Conformis Inc (CFMS), 2019-10-28
  • Director at Abpro Corp (ABP), 2018-05-11
  • Director at Oxigene Inc (OXGN), 2016-06-03
  • Vp, Cfo & Treasurer at Novavax Inc (NVAX), 2013-03-07
  • Officer at Genelabs Technologies Inc (GNLB), 2009-01-07
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
CLRB $1.04 19,417 $20,244.16 19,417 2021-09-03 Filing
MEIP $1.60 62,500 $100,000.00 62,500 2019-12-19 Filing
FLXN $9.87 2,500 $24,668.00 8,434 2016-05-17 Filing
FLXN $9.19 2,500 $22,971.75 5,934 2016-05-16 Filing
NVAX $1.18 20,000 $23,600.00 20,000 2011-08-09 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
MEIP $4.03 25,000 $100,625.00 37,500 2021-02-23 Filing
NK $10.77 5,300 $57,064.57 109,235 2020-08-11 Filing
NK $9.98 10,000 $99,787.00 114,535 2020-08-11 Filing
NK $10.22 50,000 $511,200.00 124,535 2020-08-11 Filing
FLXN $23.00 3,000 $69,000.00 7,777 2017-03-23 Filing